Literature DB >> 17068223

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Richard H Duerr1, Kent D Taylor, Steven R Brant, John D Rioux, Mark S Silverberg, Mark J Daly, A Hillary Steinhart, Clara Abraham, Miguel Regueiro, Anne Griffiths, Themistocles Dassopoulos, Alain Bitton, Huiying Yang, Stephan Targan, Lisa Wu Datta, Emily O Kistner, L Philip Schumm, Annette T Lee, Peter K Gregersen, M Michael Barmada, Jerome I Rotter, Dan L Nicolae, Judy H Cho.   

Abstract

The inflammatory bowel diseases Crohn's disease and ulcerative colitis are common, chronic disorders that cause abdominal pain, diarrhea, and gastrointestinal bleeding. To identify genetic factors that might contribute to these disorders, we performed a genome-wide association study. We found a highly significant association between Crohn's disease and the IL23R gene on chromosome 1p31, which encodes a subunit of the receptor for the proinflammatory cytokine interleukin-23. An uncommon coding variant (rs11209026, c.1142G>A, p.Arg381Gln) confers strong protection against Crohn's disease, and additional noncoding IL23R variants are independently associated. Replication studies confirmed IL23R associations in independent cohorts of patients with Crohn's disease or ulcerative colitis. These results and previous studies on the proinflammatory role of IL-23 prioritize this signaling pathway as a therapeutic target in inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17068223      PMCID: PMC4410764          DOI: 10.1126/science.1135245

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  28 in total

Review 1.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

2.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

3.  Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present.

Authors:  Andrea M Cooper; Andre Kipnis; Joanne Turner; Jeanne Magram; Jessica Ferrante; Ian M Orme
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

4.  Understanding the IL-23-IL-17 immune pathway.

Authors:  Brent S McKenzie; Robert A Kastelein; Daniel J Cua
Journal:  Trends Immunol       Date:  2005-11-14       Impact factor: 16.687

5.  Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Authors:  Sudeepta Aggarwal; Nico Ghilardi; Ming-Hong Xie; Frederic J de Sauvage; Austin L Gurney
Journal:  J Biol Chem       Date:  2002-11-03       Impact factor: 5.157

6.  Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death.

Authors:  M T Wiekowski; M W Leach; E W Evans; L Sullivan; S C Chen; G Vassileva; J F Bazan; D M Gorman; R A Kastelein; S Narula; S A Lira
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

7.  Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis.

Authors:  Christoph Becker; Heike Dornhoff; Clemens Neufert; Massimo C Fantini; Stefan Wirtz; Sabine Huebner; Alexei Nikolaev; Hans-Anton Lehr; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Peter R Galle; Margaret Karow; Markus F Neurath
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

8.  Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.

Authors:  Frank A W Verreck; Tjitske de Boer; Dennis M L Langenberg; Marieke A Hoeve; Matthijs Kramer; Elena Vaisberg; Robert Kastelein; Arend Kolk; René de Waal-Malefyt; Tom H M Ottenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

9.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

10.  Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation.

Authors:  Craig A Murphy; Claire L Langrish; Yi Chen; Wendy Blumenschein; Terrill McClanahan; Robert A Kastelein; Jonathon D Sedgwick; Daniel J Cua
Journal:  J Exp Med       Date:  2003-12-08       Impact factor: 14.307

View more
  1099 in total

1.  Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.

Authors:  Xiaoming Yin; Rauf Latif; Rebecca Bahn; Terry F Davies
Journal:  Thyroid       Date:  2012-06-04       Impact factor: 6.568

Review 2.  Considerations of traditional Chinese medicine as adjunct therapy in the management of ulcerative colitis.

Authors:  Chi Zhang; Miao Jiang; Aiping Lu
Journal:  Clin Rev Allergy Immunol       Date:  2013-06       Impact factor: 8.667

Review 3.  Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity.

Authors:  Peter J Morrison; Sarah J Ballantyne; Marika C Kullberg
Journal:  Immunology       Date:  2011-06-02       Impact factor: 7.397

Review 4.  Drug development in the era of precision medicine.

Authors:  Sarah A Dugger; Adam Platt; David B Goldstein
Journal:  Nat Rev Drug Discov       Date:  2017-12-08       Impact factor: 84.694

5.  Immune chaperone gp96 drives the contributions of macrophages to inflammatory colon tumorigenesis.

Authors:  Crystal Morales; Saleh Rachidi; Feng Hong; Shaoli Sun; Xinshou Ouyang; Caroline Wallace; Yongliang Zhang; Elizabeth Garret-Mayer; Jennifer Wu; Bei Liu; Zihai Li
Journal:  Cancer Res       Date:  2013-12-09       Impact factor: 12.701

6.  Distinct regulation of interleukin-17 in human T helper lymphocytes.

Authors:  Zhi Chen; Cristina M Tato; Linda Muul; Arian Laurence; John J O'Shea
Journal:  Arthritis Rheum       Date:  2007-09

7.  Immune response to influenza vaccine in children with inflammatory bowel disease.

Authors:  Ying Lu; Denise L Jacobson; Lori A Ashworth; Richard J Grand; Anthony L Meyer; Monica M McNeal; Matt C Gregas; Sandra K Burchett; Athos Bousvaros
Journal:  Am J Gastroenterol       Date:  2009-01-27       Impact factor: 10.864

Review 8.  Translating the Untranslated Region.

Authors:  Johannes Schwerk; Ram Savan
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

9.  Inhaled corticosteroid treatment modulates ZNF432 gene variant's effect on bronchodilator response in asthmatics.

Authors:  Ann Chen Wu; Blanca E Himes; Jessica Lasky-Su; Augusto Litonjua; Stephen P Peters; John Lima; Michiaki Kubo; Mayumi Tamari; Yusuke Nakamura; Weiliang Qiu; Scott T Weiss; Kelan Tantisira
Journal:  J Allergy Clin Immunol       Date:  2013-11-23       Impact factor: 10.793

10.  Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells.

Authors:  I H Chan; R Jain; M S Tessmer; D Gorman; R Mangadu; M Sathe; F Vives; C Moon; E Penaflor; S Turner; G Ayanoglu; C Chang; B Basham; J B Mumm; R H Pierce; J H Yearley; T K McClanahan; J H Phillips; D J Cua; E P Bowman; R A Kastelein; D LaFace
Journal:  Mucosal Immunol       Date:  2013-11-27       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.